Validation of the French version of the Revised Diagnostic Interview for Borderlines (DIB-R) for assessing the psychopathology of borderline personality disorder
Tóm tắt
Borderline personality disorder (BPD) is frequently subject to misdiagnosis or underdiagnosis. As a matter of fact, its evaluation poses several challenges, highlighting the importance of having validated evaluation instruments. The Revised Diagnostic Interview for Borderlines (DIB-R) is widely used and recognized for its validity when it comes to assessing the psychopathology of BPD, but, as for now, no French version of the interview exists. The aim of the current work is to validate a French version of the DIB-R. The sample consists of N = 65 patients with borderline personality disorder (BPD) and N = 57 treatment seeking patients (non-BPD comparison group). For inter-rater reliability, a subsample of N = 84 interviews will be assessed by two raters, n = 47 for the BPD group and n = 37 for the non-BPD comparison group. To assess reliability, we conducted analyses of internal consistency and inter-rater reliability. The results were good for the overall interview as well as for the four domains of the DIB-R. To assess validity, we calculated the receiver operating characteristic (ROC) curve, sensitivity, specificity, predictive values, convergent and discriminative validity. The optimal cutoff was found to be 7. Regarding convergent validity, we found strong convergence between the Borderline Symptom List (BSL-23) and the DIB-R total score. Additionally, the two groups statistically differed on all the DIB-R scores, which indicates that the interview discriminates between the two groups. Our results indicate good psychometric properties of the French version of the DIB-R. This has important implications as the interview is useful both in clinical settings and for research purposes. Additionally, the present paper aims to contribute to the more general effort of demonstrating generalizability and transportability of the scale.
Tài liệu tham khảo
Ellison WD, Rosenstein LK, Morgan TA, Zimmerman M. Community and clinical epidemiology of borderline personality disorder. Psychiatr Clin North Am. 2018;41(4):561–73. https://doi.org/10.1016/j.psc.2018.07.008.
Lewis KL, Fanaian M, Kotze B, Grenyer BFS. Mental health presentations to acute psychiatric services: 3-year study of prevalence and readmission risk for personality disorders compared with psychotic, affective, substance or other disorders. BJPsych Open. 2019;5(1):e1. https://doi.org/10.1192/bjo.2018.72.
Volkert J, Gablonski TC, Rabung S. Prevalence of personality disorders in the general adult population in Western countries: systematic review and meta-analysis. Br J Psychiatry. 2018;213(6):709–15. https://doi.org/10.1192/bjp.2018.202.
Leichsenring F, Leibing E, Kruse J, New AS, Leweke F. Borderline personality disorder. Lancet. 2011;377(9759):74–84. https://doi.org/10.1016/S0140-6736(10)61422-5.
Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M. Borderline personality disorder. Lancet. 2004;364(9432):453–61. https://doi.org/10.1016/S0140-6736(04)16770-6.
Paris J. Borderline personality disorder. CMAJ. 2005;172(12):1579–83. https://doi.org/10.1503/cmaj.045281.
Stoffers-Winterling JM, Storebø OJ, Pereira Ribeiro J, Kongerslev MT, Völlm BA, Mattivi JT, Faltinsen E, Todorovac A, Jørgensen MS, Callesen HE, Sales CP, Schaug JP, Simonsen E, Lieb K. Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev. 2022;11(11):CD012956. https://doi.org/10.1002/14651858.CD012956.pub2.
Biskin RS, Paris J. Diagnosing borderline personality disorder. CMAJ. 2012;184(16):1789–94. https://doi.org/10.1503/cmaj.090618.
Porr V. Real-life consequences of stigmatization, misdiagnosis, misunderstanding, and mistreatment of borderline personality disorder. Eur Psychiatry. 2017;41(Suppl):S259–60. https://doi.org/10.1016/j.eurpsy.2017.02.065.
Zimmerman M, Balling C, Dalrymple K, Chelminski I. Screening for borderline personality disorder in psychiatric outpatients with major depressive disorder and bipolar disorder. J Clin Psychiatry. 2019;80(1):18m12257. https://doi.org/10.4088/JCP.18m12257.
Shah R, Zanarini MC. Comorbidity of borderline personality disorder: current status and future directions. Psychiatr Clin North Am. 2018;41(4):583–93. https://doi.org/10.1016/j.psc.2018.07.009.
Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V. Axis I comorbidity of borderline personality disorder. Am J Psychiatry. 1998;155(12):1733–9. https://doi.org/10.1176/ajp.155.12.1733.
Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V. Axis II comorbidity of borderline personality disorder. Compr Psychiatry. 1998;39(5):296–302. https://doi.org/10.1016/s0010-440x(98)90038-4.
Zimmerman M, Mattia JI. Differences between clinical and research practices in diagnosing borderline personality disorder. Am J Psychiatry. 1999;156(10):1570–4. https://doi.org/10.1176/ajp.156.10.1570.
Fyer MR, Frances AJ, Sullivan T, Hurt SW, Clarkin J. Comorbidity of borderline personality disorder. Arch Gen Psychiatry. 1988;45(4):348–52. https://doi.org/10.1001/archpsyc.1988.01800280060008.
Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, Smith SM, Dawson DA, Pulay AJ, Pickering RP, Ruan WJ. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(4):533–45. https://doi.org/10.4088/jcp.v69n0404.
National Collaborating Centre for Mental Health (UK). Borderline Personality Disorder: Treatment and Management. NICE clinical guidelines no. 78. Leicester: British Psychological Society; 2009.
Fowler JC, Madan A, Allen JG, Oldham JM, Frueh BC. Differentiating bipolar disorder from borderline personality disorder: diagnostic accuracy of the difficulty in emotion regulation scale and personality inventory for DSM-5. J Affect Disord. 2019;245:856–60. https://doi.org/10.1016/j.jad.2018.11.079.
Ruggero CJ, Zimmerman M, Chelminski I, Young D. Borderline personality disorder and the misdiagnosis of bipolar disorder. J Psychiatr Res. 2010;44(6):405–8. https://doi.org/10.1016/j.jpsychires.2009.09.011.
Andión O, Ferrer M, Calvo N, Gancedo B, Barral C, Di Genova A, Arbos MA, Torrubia R, Casas M. Exploring the clinical validity of borderline personality disorder components. Compr Psychiatry. 2013;54(1):34–40. https://doi.org/10.1016/j.comppsych.2012.06.004.
Gunderson JG, Herpertz SC, Skodol AE, Torgersen S, Zanarini MC. Borderline personality disorder. Nat Rev Dis Primers. 2018;4:18029. https://doi.org/10.1038/nrdp.2018.29.
Aviram RB, Brodsky BS, Stanley B. Borderline personality disorder, stigma, and treatment implications. Harv Rev Psychiatry. 2006;14(5):249–56. https://doi.org/10.1080/10673220600975121.
Zanarini MC. In the fullness of time: Recovery from borderline personality disorder. 1st ed. New York: Oxford University Press; 2019.
Comtois KA, Carmel A. Borderline personality disorder and high utilization of inpatient psychiatric hospitalization: concordance between research and clinical diagnosis. J Behav Health Serv Res. 2016;43(2):272–80. https://doi.org/10.1007/s11414-014-9416-9.
Widiger TA, Samuel DB. Evidence-based assessment of personality disorders. Psychol Assess. 2005;17(3):278–87. https://doi.org/10.1037/1040-3590.17.3.278.
Paris J, Black DW. Borderline personality disorder and bipolar disorder: what is the difference and why does it matter? J Nerv Ment Dis. 2015;203(1):3–7. https://doi.org/10.1097/nmd.0000000000000225.
Carcone D, Tokarz VL, Ruocco AC. A systematic review on the reliability and validity of semistructured diagnostic interviews for borderline personality disorder. Can Psychol. 2015;56(2):208–26. https://doi.org/10.1037/cap0000026.
Zanarini MC, Gunderson JG, Frankenburg FR, Chauncey DL. The revised diagnostic interview for borderlines: discriminating BPD from other Axis II disorders. J Pers Disord. 1989;3:10–8.
Gunderson JG, Kolb JE, Austin V. The diagnostic interview for borderline patients. Am J Psychiatry. 1981;138(7):896–903. https://doi.org/10.1176/ajp.138.7.896.
Zanarini MC, Frankenburg FR, Vujanovic AA. Inter-rater and test-retest reliability of the Revised Diagnostic Interview for Borderlines. J Pers Disord. 2002;16(3):270–6. https://doi.org/10.1521/pedi.16.3.270.22538.
Wang L, Yuan C, Qiu J, Gunderson J, Zhang M, Jiang K, Leung F, Zhong J, Xiao Z. Reliability and validity of a Chinese version of the Diagnostic Interview for Borderlines-Revised. Asia Pac Psychiatry. 2014;6(3):326–33. https://doi.org/10.1111/appy.12111.
Szerman N, Peris MD, Ruiz A, Ruiz M, Gunderson JG, Rejas J, Study Group for the Validation of the DIB-R into Spanish. Linguistic adaptation and validation into Spanish of the Diagnostic Interview for Borderline Personality Disorders-Revised (DIB-R). Curr Med Res Opin. 2005;21(8):1251–9. https://doi.org/10.1185/030079905X56385.
Barrachina J, Soler J, Campins MJ, Tejero A, Pascual JC, Alvarez E, Zanarini MC, Pérez SV. Validación de la versión española de la Diagnostic Interview for Bordelines-Revised (DIB-R) [Validation of a Spanish version of the Diagnostic Interview for Bordelines-Revised (DIB-R)]. Actas Esp Psiquiatr. 2004;32(5):293–8.
First MB, Williams JB, Karg RS, Spitzer RL. Structured clinical interview for DSM-5 disorders: SCID-5-CV clinician version. Arlington, VA: American Psychiatric Association Press; 2016.
Bohus M, Kleindienst N, Limberger MF, Stieglitz RD, Domsalla M, Chapman AL, Steil R, Philipsen A, Wolf M. The short version of the Borderline Symptom List (BSL-23): development and initial data on psychometric properties. Psychopathology. 2009;42(1):32–9. https://doi.org/10.1159/000173701.
Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6(4):284–90. https://doi.org/10.1037/1040-3590.6.4.284.
Zimmerman M. Diagnosing personality disorders. A review of issues and research methods. Arch Gen Psychiatry. 1994;51(3):225–45.
Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Pers Disord. 2003;17(6):568–73.
Zanarini MC, Gunderson JG, Frankenburg FR, Chauncey DL. Discriminating borderline personality disorder from other axis II disorders. Am J Psychiatry. 1990;147(2):161–7. https://doi.org/10.1176/ajp.147.2.161.
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417–32. https://doi.org/10.1016/0895-4356(93)90142-N.